SEREVENTDISKUS (Dispensing Solutions, Inc.)
Welcome to the PulseAid listing for the SEREVENT drug offered from Dispensing Solutions, Inc.. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dispensing Solutions, Inc. |
NON-PROPRIETARY NAME: | salmeterol xinafoate |
SUBSTANCE NAME: | SALMETEROL XINAFOATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
ROUTE: | ORAL; RESPIRATORY (INHALATION) |
DOSAGE FORM: | POWDER, METERED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-11-25 |
END MARKETING DATE: | 0000-00-00 |
SEREVENT DISKUS HUMAN PRESCRIPTION DRUG Details:
Item Description | SEREVENT DISKUS from Dispensing Solutions, Inc. |
LABELER NAME: | Dispensing Solutions, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(ug/1) |
START MARKETING DATE: | 1997-11-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68258-8961_198f20a2-218e-4a0f-a4c1-ae7c3b62e1c6 |
PRODUCT NDC: | 68258-8961 |
APPLICATION NUMBER: | NDA020692 |
Other SALMETEROL XINAFOATE Pharmaceutical Manufacturers / Labelers: